---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-012648"
form_type: "8-K"
ticker: "CRVL"
cik: "0000874866"
company_name: "CORVEL CORP"
filed_at: "2025-02-04T23:59:59+00:00"
generated_at: "2026-05-27T03:47:53.823617+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CorVel Q3 FY2025 revenue up 13% to $228M; EPS $0.46 (+39% YoY)

## Summary
- Revenue $228M vs $202M YoY; gross profit $52.9M at 23.2% margin (+25%).
- Diluted EPS $0.46 vs $0.33 YoY; nine-month EPS $1.32 vs $1.09.
- Cash $163M, no borrowings; repurchased $9.6M of stock during quarter.
- Released generative-AI features for document processing and claim milestones.
- CERIS platform sees increased demand from ASO customers seeking medical cost savings.

## SEC filing metadata
- accession: 0000950170-25-012648
- form_type: 8-K
- ticker: CRVL
- cik: 0000874866
- company_name: CORVEL CORP
- filed_at: 2025-02-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/874866/000095017025012648/0000950170-25-012648-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/874866/000095017025012648/crvl-20250204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-012648
- JSON: https://secwatch.observer/filing/0000950170-25-012648.json
- Plain text: https://secwatch.observer/filing/0000950170-25-012648.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.